Literature DB >> 8909457

Noninvasive perfusion MRI in Alzheimer's disease: a preliminary report.

T A Sandson1, M O'Connor, R A Sperling, R R Edelman, S Warach.   

Abstract

We performed functional MRI using the echo-planar imaging and signal targeting with alternating radio frequency (EPISTAR) technique in 11 patients with Alzheimer's disease (AD) and 8 age-matched control subjects. Seven of the AD patients had qualitatively apparent focal areas of hypoperfusion in the posterior temporoparietal-occipital regions. At the earliest inversion time producing cortical enhancement, the ratios of parieto-occipital and temporo-occipital to whole slice signal intensity were significantly lower in the AD patients than in the controls. Parieto-occipital hypoperfusion correlated with dementia severity as measured by the Blessed Dementia Scale. EPISTAR may prove to be a rapid, noninvasive alternative to other functional neuroimaging modalities in the evaluation of patients with dementia.

Entities:  

Mesh:

Year:  1996        PMID: 8909457     DOI: 10.1212/wnl.47.5.1339

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

Review 1.  Science, medicine, and the future: functional magnetic resonance imaging in neuropsychiatry.

Authors:  C Longworth; G Honey; T Sharma
Journal:  BMJ       Date:  1999-12-11

2.  Arterial spin labeling in neuroimaging.

Authors:  Sasitorn Petcharunpaisan; Joana Ramalho; Mauricio Castillo
Journal:  World J Radiol       Date:  2010-10-28

Review 3.  Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.

Authors:  Christina E Wierenga; Chelsea C Hays; Zvinka Z Zlatar
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

4.  Measurement of cerebral perfusion with arterial spin labeling: Part 2. Applications.

Authors:  Gregory G Brown; Camellia Clark; Thomas T Liu
Journal:  J Int Neuropsychol Soc       Date:  2007-05       Impact factor: 2.892

5.  Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease.

Authors:  Iris Asllani; Christian Habeck; Nikolaos Scarmeas; Ajna Borogovac; Truman R Brown; Yaakov Stern
Journal:  J Cereb Blood Flow Metab       Date:  2007-10-24       Impact factor: 6.200

Review 6.  Clinical neuroimaging using arterial spin-labeled perfusion magnetic resonance imaging.

Authors:  Ronald L Wolf; John A Detre
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

7.  Glyconanoparticle aided detection of β-amyloid by magnetic resonance imaging and attenuation of β-amyloid induced cytotoxicity.

Authors:  Hovig Kouyoumdjian; David C Zhu; Mohammad H El-Dakdouki; Kelly Lorenz; Jianjun Chen; Wei Li; Xuefei Huang
Journal:  ACS Chem Neurosci       Date:  2013-01-16       Impact factor: 4.418

8.  Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease.

Authors:  Maximilian Wiesmann; Monica Roelofs; Robert van der Lugt; Arend Heerschap; Amanda J Kiliaan; Jurgen Ahr Claassen
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 9.  The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease.

Authors:  Chelsea C Hays; Zvinka Z Zlatar; Christina E Wierenga
Journal:  Cell Mol Neurobiol       Date:  2016-02-22       Impact factor: 5.046

10.  Compromised hemodynamic response in amyloid precursor protein transgenic mice.

Authors:  Thomas Mueggler; Christine Sturchler-Pierrat; Diana Baumann; Martin Rausch; Matthias Staufenbiel; Markus Rudin
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.